tiprankstipranks
Inspire Medical Systems Sees Strong Q3 Growth in 2024
Company Announcements

Inspire Medical Systems Sees Strong Q3 Growth in 2024

Don't Miss our Black Friday Offers:

Inspire Medical Systems ( (INSP) ) has provided an update.

Inspire Medical Systems reported a robust third quarter for 2024, with a 33% increase in revenue, reaching $203.2 million, and earnings per share of $0.60. The company expanded its U.S. operations by activating 66 new medical centers and creating 13 new sales territories. Inspire also raised its full-year revenue and earnings guidance due to strong business performance and FDA approval of its Inspire V neurostimulation system, reinforcing its position as a key player in treating obstructive sleep apnea.

For a thorough assessment of INSP stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyTarget downgraded, Chewy upgraded: Wall Street’s top analyst calls
TheFlyInspire Medical upgraded to Buy at BofA on durable margin upside
TheFlyInspire Medical upgraded to Buy from Neutral at BofA
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App